BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 16580578)

  • 1. Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats.
    El Midaoui A; Wu L; Wang R; de Champlain J
    Am J Hypertens; 2006 Apr; 19(4):407-12. PubMed ID: 16580578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
    Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
    Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of PPAR-gamma knock-down and hyperglycemia on insulin signaling in vascular smooth muscle cells from hypertensive rats.
    Pandey NR; Benkirane K; Amiri F; Schiffrin EL
    J Cardiovasc Pharmacol; 2007 Jun; 49(6):346-54. PubMed ID: 17577098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
    Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
    Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes.
    Koçak G; Aktan F; Canbolat O; Ozoğul C; Elbeğ S; Yildizoglu-Ari N; Karasu C;
    Diabetes Nutr Metab; 2000 Dec; 13(6):308-18. PubMed ID: 11232755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidiabetic and hypolipidemic potential of DRF 2519--a dual activator of PPAR-alpha and PPAR-gamma.
    Chakrabarti R; Misra P; Vikramadithyan RK; Premkumar M; Hiriyan J; Datla SR; Damarla RK; Suresh J; Rajagopalan R
    Eur J Pharmacol; 2004 May; 491(2-3):195-206. PubMed ID: 15140637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production.
    Midaoui AE; Elimadi A; Wu L; Haddad PS; de Champlain J
    Am J Hypertens; 2003 Mar; 16(3):173-9. PubMed ID: 12620694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of glucose and insulin on the development of oxidative stress and hypertension in animal models of type 1 and type 2 diabetes.
    El Midaoui A; de Champlain J
    J Hypertens; 2005 Mar; 23(3):581-8. PubMed ID: 15716700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts.
    Zhang J; Fang NY; Gao PJ; Wu LY; Han WQ; Guo SJ; Shen WL; Zhu DL
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):72-7. PubMed ID: 18047631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor gamma ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2.
    Wakino S; Hayashi K; Kanda T; Tatematsu S; Homma K; Yoshioka K; Takamatsu I; Saruta T
    Circ Res; 2004 Sep; 95(5):e45-55. PubMed ID: 15308580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired expression of PPAR gamma protein contributes to the exaggerated growth of vascular smooth muscle cells in spontaneously hypertensive rats.
    Xiong C; Mou Y; Zhang J; Fu M; Chen YE; Akinbami MA; Cui T
    Life Sci; 2005 Oct; 77(24):3037-48. PubMed ID: 15970297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of peroxisome proliferator-activated receptors Y changes with age in vascular smooth muscle cells of spontaneously hypertensive rat].
    Di ZL; Niu XL; Wei J; Li YQ; Chen GL; Wang NP
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):204-7. PubMed ID: 16608075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of PPAR gamma agonists on cardiovascular function in obese, non-diabetic patients.
    Panunti B; Fonseca V
    Vascul Pharmacol; 2006 Jul; 45(1):29-35. PubMed ID: 16777491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of natriuretic peptide receptor-C attenuates the enhanced oxidative stress in vascular smooth muscle cells from spontaneously hypertensive rats: implication of Gialpha protein.
    Saha S; Li Y; Lappas G; Anand-Srivastava MB
    J Mol Cell Cardiol; 2008 Feb; 44(2):336-44. PubMed ID: 18162186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature.
    Duan SZ; Usher MG; Mortensen RM
    Circ Res; 2008 Feb; 102(3):283-94. PubMed ID: 18276926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of kinin B1 receptor and oxidative stress in sensory abnormalities and arterial hypertension in an experimental rat model of insulin resistance.
    Lungu C; Dias JP; França CE; Ongali B; Regoli D; Moldovan F; Couture R
    Neuropeptides; 2007 Dec; 41(6):375-87. PubMed ID: 17988733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
    Touyz RM; Schiffrin EL
    Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of hypertension, insulin resistance, and oxidative stress by alpha-lipoic acid.
    El Midaoui A; de Champlain J
    Hypertension; 2002 Feb; 39(2):303-7. PubMed ID: 11847202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiomyocytic apoptosis following global cardiac ischemia and reperfusion can be attenuated by peroxisome proliferator-activated receptor alpha but not gamma activators.
    Yeh CH; Chen TP; Lee CH; Wu YC; Lin YM; Lin PJ
    Shock; 2006 Sep; 26(3):262-70. PubMed ID: 16912651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PPARgamma ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice.
    Hwang J; Kleinhenz DJ; Rupnow HL; Campbell AG; Thulé PM; Sutliff RL; Hart CM
    Vascul Pharmacol; 2007 Jun; 46(6):456-62. PubMed ID: 17337254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.